M. Rosenthal

1.9k total citations
64 papers, 1.3k citations indexed

About

M. Rosenthal is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, M. Rosenthal has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 13 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in M. Rosenthal's work include Rheumatoid Arthritis Research and Therapies (11 papers), Pharmacological Effects of Natural Compounds (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). M. Rosenthal is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Pharmacological Effects of Natural Compounds (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). M. Rosenthal collaborates with scholars based in United States, Switzerland and Belgium. M. Rosenthal's co-authors include J. Symoens, Wernér E.G. Müller, John W. Kreider, F.R. Sallee, Robert Riesenberg, Jack Mardekian, Edwin H. Cook, Karen Dineen Wagner, B. Müller and Roberto Domı́nguez and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

M. Rosenthal

63 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Rosenthal United States 18 399 216 199 175 171 64 1.3k
Allison L. Miller New Zealand 26 291 0.7× 188 0.9× 361 1.8× 118 0.7× 436 2.5× 57 1.9k
S. Malhotra India 17 136 0.3× 201 0.9× 301 1.5× 77 0.4× 141 0.8× 42 1.0k
Patricia Murphy Canada 22 107 0.3× 308 1.4× 158 0.8× 87 0.5× 622 3.6× 51 2.0k
Akiko Kikuchi Japan 21 170 0.4× 168 0.8× 540 2.7× 71 0.4× 369 2.2× 108 1.8k
Laura E. Pope United States 19 91 0.2× 213 1.0× 172 0.9× 147 0.8× 347 2.0× 42 1.6k
Peter R. Casson United States 30 162 0.4× 665 3.1× 139 0.7× 149 0.9× 521 3.0× 84 3.4k
Ulrike Kaufmann Austria 28 118 0.3× 66 0.3× 267 1.3× 36 0.2× 684 4.0× 77 2.1k
Wei Qu China 20 255 0.6× 49 0.2× 149 0.7× 29 0.2× 333 1.9× 59 1.4k
Jian Hu China 23 183 0.5× 306 1.4× 22 0.1× 153 0.9× 430 2.5× 71 1.3k
Zhongshan Cheng United States 19 192 0.5× 71 0.3× 273 1.4× 106 0.6× 421 2.5× 42 2.1k

Countries citing papers authored by M. Rosenthal

Since Specialization
Citations

This map shows the geographic impact of M. Rosenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rosenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rosenthal more than expected).

Fields of papers citing papers by M. Rosenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rosenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rosenthal. The network helps show where M. Rosenthal may publish in the future.

Co-authorship network of co-authors of M. Rosenthal

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rosenthal. A scholar is included among the top collaborators of M. Rosenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rosenthal. M. Rosenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jhee, S. S., Amy S. Chappell, Victoria Zarotsky, et al.. (2006). Multiple‐Dose Plasma Pharmacokinetic and Safety Study of LY450108 and LY451395 (AMPA Receptor Potentiators) and Their Concentration in Cerebrospinal Fluid in Healthy Human Subjects. The Journal of Clinical Pharmacology. 46(4). 424–432. 26 indexed citations
3.
March, John S., Joseph Biederman, Robert Wolkow, et al.. (1998). Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder. JAMA. 280(20). 1752–1752. 322 indexed citations
4.
Tung, Avery & M. Rosenthal. (1995). Patients requiring sedation.. PubMed. 11(4). 791–802. 34 indexed citations
5.
Baker, Dewleen G., B.I. Diamond, Mark B. Hamner, et al.. (1995). A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology. 122(4). 386–389. 82 indexed citations
6.
Katz, Richard J., Phyllis Landau, Alexander Bystritsky, et al.. (1993). Serotonergic (5-HT2) mediation of anxiety-therapeutic effects of serazepine in generalized anxiety disorder. Biological Psychiatry. 34(1-2). 41–44. 22 indexed citations
7.
Schweizer, Edward E., William M. Patterson, Karl Rickels, & M. Rosenthal. (1992). A ONCE-A-DAY, SLOW-RELEASE FORM OF ALPRAZOLAM FOR THE TREATMENT OF PANIC DISORDER: A PLACEBO-CONTROLLED STUDY. Clinical Neuropharmacology. 15. 26B–26B. 1 indexed citations
8.
Rosenthal, M.. (1984). The efficacy of flurbiprofen versus piroxicam in the treatment of acute soft tissue rheumatism. Current Medical Research and Opinion. 9(5). 304–309. 13 indexed citations
9.
Adam, R., Eric Veys, E.C. HUSKISSON, et al.. (1982). Levamisole in rheumatoid arthritis. Final report on a randomised double-blind study comparing a single weekly dose of levamisole with placebo. Multicentre Study Group.. Annals of the Rheumatic Diseases. 41(2). 159–163. 7 indexed citations
10.
Veys, E M, E.C. HUSKISSON, M. Rosenthal, et al.. (1982). Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Annals of the Rheumatic Diseases. 41(5). 441–443. 19 indexed citations
11.
Rosenthal, M.. (1978). Lebensalter und Immunit�t. Annals of Hematology. 37(5). 271–274. 5 indexed citations
12.
Lavanchy, Daniel & M. Rosenthal. (1978). [Lymphocyte stimulation in various age groups].. PubMed. 108(15). 551–5. 5 indexed citations
13.
Rosenthal, M.. (1978). A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.. PubMed. 4. 97–100. 7 indexed citations
14.
Sundal, E, et al.. (1977). [Allergic reaction to meningococcal antigen. Clinical aspects, pathogenesis and diagnosis related to a case history].. PubMed. 107(50). 1900–3. 2 indexed citations
15.
Rosenthal, M., et al.. (1976). Levamisole in Sarcoidosis. New England Journal of Medicine. 294(2). 112–113. 10 indexed citations
16.
Rosenthal, M., et al.. (1976). The effect of levamisole on adjuvant arthritis in the rat.. PubMed. 3(2). 165–74. 10 indexed citations
17.
Rosenthal, M., et al.. (1976). [Therapy of inflammatory-rheumatic diseases with levamisol, an immunity modulating substance].. PubMed. 106(39). 1293–301. 4 indexed citations
18.
Rosenthal, M., et al.. (1976). Immunotherapy with Levamisole in Rheumatic Diseases. Scandinavian Journal of Rheumatology. 5(4). 216–220. 17 indexed citations
19.
Rosenthal, M., et al.. (1975). LYMPHOKINES IN RHEUMATOID SYNOVITIS. Annals of the New York Academy of Sciences. 256(1). 117–131. 34 indexed citations
20.
Rosenthal, M., et al.. (1975). Enhancement of immunoglobulin and rheumatoid factor synthesis by rheumatoid synovial effusions and synovial membrane culture supernatants.. PubMed. 6. 87–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allison L. Miller Breakdown of academic impact, for papers by S. Malhotra Breakdown of academic impact, for papers by Patricia Murphy Breakdown of academic impact, for papers by Akiko Kikuchi Breakdown of academic impact, for papers by Laura E. Pope Breakdown of academic impact, for papers by Peter R. Casson Breakdown of academic impact, for papers by Ulrike Kaufmann Breakdown of academic impact, for papers by Wei Qu Breakdown of academic impact, for papers by Jian Hu Breakdown of academic impact, for papers by Zhongshan Cheng
Rankless by CCL
2026